THERAPY WITH DIVIDED DOSAGES OF AGENTS OF VASCULODESTROYING ACTIVITY Russian patent published in 2006 - IPC A61K31/661 A61P35/00 

FIELD: medicine.

SUBSTANCE: the present innovation deals with applying a vasculodestroying agent or its pharmaceutically acceptable salt to be introduced for a warm-blooded animal as divided dosages to obtain anti-tumor effect. In particular, a vasculodestroying agent is being ZD6126, AC-7700, combrestatin A4 phosphate or their pharmaceutically acceptable salts. Moreover, total daily dosage of vasculodestroying agent is divided into two or more equal or unequal parts, and interval of time between introduction of every part corresponds to above 0 to about 6 h. The innovation enables to obtain greater anti-tumor effect against the one obtained at introducing the same total dosage of vasculodestroying agent as a single dosage.

EFFECT: higher efficiency of therapy.

18 cl, 2 dwg